AAAAAA

   
Results: 1-17 |
Results: 17
Protection from obesity in mice lacking the VLDL receptor
Authors: Goudriaan, JR Tacken, PJ Dahlmans, VEH Gijbels, MJJ van Dijk, KW Havekes, LM Jong, MC
Citation: Jr. Goudriaan et al., Protection from obesity in mice lacking the VLDL receptor, ART THROM V, 21(9), 2001, pp. 1488-1493
Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice
Authors: Jong, MC Rensen, PCN Dahlmans, VEH van der Boom, H van Berkel, TJC Havekes, LM
Citation: Mc. Jong et al., Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice, J LIPID RES, 42(10), 2001, pp. 1578-1585
Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1
Authors: Koopmans, SJ Jong, MC Que, I Dahlmans, VEH Pijl, H Radder, JK Frolich, M Havekes, LM
Citation: Sj. Koopmans et al., Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1, DIABETOLOG, 44(4), 2001, pp. 437-443
In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake
Authors: Voshol, PJ Jong, MC Dahlmans, VEH Kratky, D Levak-Frank, S Zechner, R Romijn, JA Havekes, LM
Citation: Pj. Voshol et al., In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake, DIABETES, 50(11), 2001, pp. 2585-2590
Apolipoprotein E2 (Lys146 -> Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low densitylipoproteins-triglycerides
Authors: de Beer, F van Dijk, KW Jong, MC van Vark, LC van der Zee, A Hofker, MH Fallaux, FJ Hoeben, RC Smelt, AHM Havekes, LM
Citation: F. De Beer et al., Apolipoprotein E2 (Lys146 -> Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low densitylipoproteins-triglycerides, ART THROM V, 20(7), 2000, pp. 1800-1806
Cafestol increases serum cholesterol levels in apolipoprotein E3-Leiden transgenic mice by suppression of bile acid synthesis
Authors: Post, SM de Roos, B Vemeulen, M Afman, L Jong, MC Dahlmans, VEH Havekes, LM Stellaard, F Katan, MB Princen, HMG
Citation: Sm. Post et al., Cafestol increases serum cholesterol levels in apolipoprotein E3-Leiden transgenic mice by suppression of bile acid synthesis, ART THROM V, 20(6), 2000, pp. 1551-1556
Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis
Authors: Jong, MC Hendriks, WL van Vark, LC Dahlmans, VEH Groener, JEM Havekes, LM
Citation: Mc. Jong et al., Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis, ART THROM V, 20(1), 2000, pp. 144-151
Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice
Authors: Jong, MC Havekes, LM
Citation: Mc. Jong et Lm. Havekes, Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice, INT J TISS, 22(2-3), 2000, pp. 59-66
Hepatic lipid accumulation, altered very low density lipoprotein formationand apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice
Authors: Mensenkamp, AR van Luyn, MJA van Goor, H Bloks, V Apostel, F Greeve, J Hofker, MH Jong, MC van Vlijmen, BJM Havekes, LM Kuipers, F
Citation: Ar. Mensenkamp et al., Hepatic lipid accumulation, altered very low density lipoprotein formationand apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice, J HEPATOL, 33(2), 2000, pp. 189-198
Genomic interval engineering of mice identifies a novel modulator of triglyceride production
Authors: Zhu, YW Jong, MC Frazer, KA Gong, E Krauss, RM Cheng, JF Boffelli, D Rubin, EM
Citation: Yw. Zhu et al., Genomic interval engineering of mice identifies a novel modulator of triglyceride production, P NAS US, 97(3), 2000, pp. 1137-1142
LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice
Authors: Tacken, PJ Teusink, B Jong, MC Harats, D Havekas, LM van Dijk, KW Hofker, MH
Citation: Pj. Tacken et al., LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice, J LIPID RES, 41(12), 2000, pp. 2055-2062
Apolipoprotein E is resistant to intracellular degradation in vitro and invivo - Evidence for retroendocytosis
Authors: Rensen, PCN Jong, MC van Vark, LC van der Boom, H Hendriks, WL van Berkel, TJC Biessen, EAL Havekes, LM
Citation: Pcn. Rensen et al., Apolipoprotein E is resistant to intracellular degradation in vitro and invivo - Evidence for retroendocytosis, J BIOL CHEM, 275(12), 2000, pp. 8564-8571
Role of ApoCs in lipoprotein metabolism - Functional differences between ApoC1, ApoC2, and ApoC3
Authors: Jong, MC Hofker, MH Havekes, LM
Citation: Mc. Jong et al., Role of ApoCs in lipoprotein metabolism - Functional differences between ApoC1, ApoC2, and ApoC3, ART THROM V, 19(3), 1999, pp. 472-484
Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor
Authors: Jong, MC Van Dijk, KW Dahlmans, VEH Van der Boom, H Kobayashi, K Oka, K Siest, G Chan, L Hofker, MH Havekes, LM
Citation: Mc. Jong et al., Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor, BIOCHEM J, 338, 1999, pp. 281-287
Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver
Authors: Mensenkamp, AR Jong, MC van Goor, H van Luyn, MJA Bloks, V Havinga, R Voshol, PJ Hofker, MH van Dijk, KW Havekes, LM Kuipers, F
Citation: Ar. Mensenkamp et al., Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver, J BIOL CHEM, 274(50), 1999, pp. 35711-35718
Alcalase-catalyzed synthesis of novel 2,6-dimethoxyhydroquinone-3-mercaptoacetyl-peptide conjugates
Authors: Chen, WF Jong, MC Chen, ST Sheh, L
Citation: Wf. Chen et al., Alcalase-catalyzed synthesis of novel 2,6-dimethoxyhydroquinone-3-mercaptoacetyl-peptide conjugates, J CHIN CHEM, 46(1), 1999, pp. 127-129
Effects of fenofibrate on hyperlipidemia and postprandial triglyceride metabolism in human apolipoprotein C1 transgenic mice
Authors: Jong, MC Dahlmans, VEH Princen, HMG Hofker, MH Havekes, LM
Citation: Mc. Jong et al., Effects of fenofibrate on hyperlipidemia and postprandial triglyceride metabolism in human apolipoprotein C1 transgenic mice, ATHEROSCLER, 141, 1998, pp. S77-S80
Risultati: 1-17 |